strategic alternatives Qiagen Completes Strategic Review, Rejects Acquisition Offers The firm had received interest from unnamed potential acquisition partners following the departure of its CEO, but it has decided to remain as a standalone business. Curetis Hires Strategic Advisor, Delays Release of Financial Results The company is delaying the publication of its business and financial update for the first half of 2019 to allow for an ongoing review by its auditors. Enzo Biochem Fiscal Q3 Revenues Decline 22 Percent The company's clinical services revenues were down 34 percent year over year while product revenues ticked up 7 percent. Cancer Genetics Selling Indian Subsidiary to Reprocell for up to $1.9M The firm is selling BioServe to Reprocell as part of Cancer Genetics' transformation and strategic plan to bring itself to profitability. Class Action Lawsuits Filed Against Cancer Genetics The lawsuits allege the company made false and/or misleading statement and/or failed to disclose information that was pertinent to investors. Apr 2, 2018 Cancer Genetics Q4 Revenues Grow 4 Percent Dec 12, 2017 Genetic Technologies Faces Shareholder Revolt as It Mulls Strategic Alternatives Aug 25, 2017 Genetic Technologies Exploring Strategic Alternatives Sep 5, 2014 Nanosphere Exploring Strategic Alternatives, Hires Jefferies as Advisor Sep 24, 2013 Sequenom Board Authorizes Review of Strategic Alternatives for Genetic Analysis Business Feb 1, 2013 Axela Hires Investment Bank to Explore Strategic Opportunities, Including Potential Sale Nov 19, 2012 SQI Diagnostics May Seek Merger or Sale Jun 5, 2012 Complete Genomics Fires 55 Staffers, Delays Capacity Expansion as it Explores Strategic Alternatives Dec 14, 2011 Ocimum Biosolutions/Gene Logic Files for Chapter 11, Seeks Bidders Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.